DNA Markets

DNA Markets is an Australian-based online trading provider that entered the retail forex and CFD space in late 2022, officially launching its operations in 2023. The company operates from a prestigious office address at South Tower, Level 35, 525 Collins Street, Melbourne, positioning itself as a modern fintech broker.

Despite its relatively recent market entry, DNA Markets has quickly gained visibility among traders searching for tight spreads and a straightforward MT5 trading experience. The brokerage is owned and operated by Focus Markets Pty Ltd, an entity that is reportedly involved in the financial services sector in Australia.

DNA Markets holds an Australian Financial Services Licence (AFSL) issued by the Australian Securities and Investments Commission (ASIC), licence number 514425. ASIC is widely regarded as a Tier-1 regulator with stringent capital and compliance requirements, providing a baseline of trust for retail traders.

However, it is important to note that ASIC regulation primarily ensures compliance with Australian laws, and while it mandates client money segregation, it does not offer an investor compensation fund akin to the UK's FSCS. Traders should be aware that the regulatory protections may have limitations, especially when dealing with international clients or complex corporate structures.

DNA Markets offers multiple account types designed to suit various trading preferences, from beginners to high-volume professionals. While detailed specifications on minimum deposits and leverage are not prominently published, the broker suggests that its raw spread account is a key attraction, offering near-zero spreads on major pairs like EURUSD and GBPUSD.

The firm's own materials highlight a frictionless account opening process, quick funding, and support for popular trading strategies including scalping and automated trading. Promised maximum leverage on certain instruments reaches up to 1:30 for retail clients under ASIC rules, though higher leverage may be available through its international entity under different jurisdictions.

Trading is conducted exclusively through MetaTrader 5 (MT5), the multi-asset platform favoured for its advanced charting tools, automated trading capabilities via Expert Advisors, and built-in economic calendar. MT5 provides access to DNA Markets' asset universe of over 800 instruments, covering forex majors, minors, and exotics, as well as a broad selection of commodities, indices, shares, and cryptocurrencies.

The broker claims that traders can execute orders with minimal latency, supported by robust infrastructure. The combination of MT5 and a wide instrument range positions DNA Markets as a potentially attractive hub for diversified portfolio traders.

DNA Markets supports a range of deposit and withdrawal methods commonly used by retail traders, including bank wire transfers, credit/debit cards, and e-wallets such as Skrill and Neteller. The broker states that deposits are typically credited instantly or within one business day, and withdrawal requests are processed swiftly, often on the same day.

Client funds are claimed to be held in segregated accounts at top-tier Australian banks, providing a layer of protection. However, the fine print reveals that client accounts may be opened under an international entity, Focus Markets LLC, which could affect the applicability of these protections for non-Australian traders.

With its emphasis on tight spreads and MT5 execution, DNA Markets primarily appeals to scalpers, day traders, and algorithm developers who rely on minimal trading costs and low latency. The broker’s Discord community adds a social dimension for those who value peer interaction.

At the same time, the lack of extensive educational resources and the somewhat dated client dashboard make it less suitable for absolute beginners. Moreover, traders who insist on the strongest possible regulatory safeguards should carefully scrutinise the broker's corporate structure before committing capital. For a deeper, evidence-based assessment, read our full FXCanary investigation below.